Veefin transitioned into a multi-product BFSI tech platform, reporting strong standalone growth for FY26 with significant expansion into international markets and non-supply chain finance products.
FY26 was a transitional 'stormy' year for CMS, hit by prolonged SBI outsourcing delays and consumption headwinds. Management is pivoting towards fixed-fee models to escape the 'dead' transaction-fee ATM business.
Endurance reported strong FY26 revenue growth but faces near-term EBITDA pressure from commodity inflation and energy spikes. Management is aggressively pivoting to EV-specific components and higher-value technology products like ABS.
Park Medi World delivered record FY26 results with Revenue up 21% to ₹1,679cr and PAT up 27% to ₹274cr, driven by record patient volumes and capacity expansion.
SPR Auto Technologies (formerly Shriram Pistons) reported a landmark FY26 with record total income of ₹4,571cr and EBITDA of ₹989cr, driven by acquisitions and strong domestic demand.
Bank of India reported a strong FY26 with Net Profit rising 14% YoY to ₹10,527 crore. Strategy focuses on RAM book expansion (target 62%) and improving domestic NIM towards 3%.
Aakaar Medical Technologies reported H2FY26 revenue of ₹41.6 Cr and PAT of ₹7.4 Cr, successfully pivoting to higher-margin owned brands and cash-first billing.
Aurionpro's FY26 revenue grew 20.2% to ₹1,411 Cr, but missed internal 30% targets due to Middle East (MEA) geopolitical delays and hyperscaler project shifts. Strategy focuses on AI-native Banking and Transit stacks.
Hester Biosciences delivered a strong Q3 FY26 with standalone revenue up 12% and PAT up 140%, driven by robust Poultry Healthcare performance and operational leverage despite Animal Healthcare headwinds.
Rashi Peripherals delivered record FY26 revenues driven by a generational PC refresh cycle and AI infrastructure demand, though margins remain razor-thin as a value-added distributor.